How long and how much? Bringing a biotech crop to market costs $116 million and takes 16.5 years

Credit: Shutterstock
Credit: Shutterstock

Farmers are increasingly faced with the need to produce more food from fewer resources and under less predictable growing conditions. They are also tasked with managing the broader landscape within which they farm and mitigating the effects of climate change.

Each year, millions of farmers around the world plant biotech crops for higher yields, improved crop quality, and the ability to use sustainable farming practices such as no-till. Getting these innovative new genetically modified (GM) traits from the lab to their fields requires a tremendous investment from product developers.

  • The good news is that the cost of discovery, development, and authorization of a new GM trait has declined by $21 million over the past 10 years. However, more importantly, the time to get these new innovations to market has increased from 13.1 years to 16.5 years.
  • Despite product developers improving parts of the research and development process, it is taking them longer to realize a return on their investment. And just as important, it is taking longer to get these new innovations into the hands of farmers.
  • This report demonstrates that now more than ever, a more harmonized regulatory framework around the world for GM traits would improve time to market, which promotes innovation and ultimately helps farmers and consumers.
Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

Key findings of the study include

The regulatory phase, the longest duration of the overall process, accounted for almost 40% (37.6%) of the total cost of commercialization and more importantly more than half (51.1%) of the time. This increase in time reflects an increase of almost 140% over the 2008-2012 study and an additional 40 months of lost commercial revenue for product developers.

[Editor’s note: Read the entire report here: Time and Cost to Develop a New GM Trait.]

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
ChatGPT-Image-Jun-23-2026-03_12_23-PM
Is cellular reprogramming junk science? Nearly 20 patients are getting eye injections in the first FDA-cleared cellular trial
Screenshot-2026-06-15-at-1.55.27-PM
America's trust in Trump-Kennedy's CDC health recommendations is plunging
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT-Image-Jun-24-2026-11_36_47-AM
Why the human genome is less a script than a puzzle
ChatGPT-Image-Jun-17-2026-10_52_43-AM
Anguished parents, doctors in tears: Utah’s long measles outbreak takes a toll
Screenshot 2026-06-25 at 10.55
Leading OB-GYN group challenges RFK, Jr. gutting of maternal vaccine schedule
Screenshot-2026-06-24-at-2.57.41-PM
Viewpoint: Trump’s Reflecting Pool algae fiasco points to a bigger culprit: Climate change
Screenshot-2026-06-24-at-2.40.46-PM
Hegseth reversal: As Air Force flu outbreak continues to surge, military reinstitutes mandatory vaccines for recruits
ChatGPT-Image-May-18-2026-12_06_18-PM-2
Defying death: The immortality movement goes mainstream

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.